References
- Abraham C, Cho JH. (2009). Inflammatory bowel disease. N Engl J Med 361:2066–78
- Appenzeller-Herzog C. (2011). Glutathione- and non-glutathione-based oxidant control in the endoplasmic reticulum. J Cell Sci 124:847–55
- Atyabi F, Moghaddam FA, Dinarvand R, et al. (2008). Thiolated chitosan coated poly hydroxyethyl methacrylate nanoparticles: synthesis and characterization. Carbohydr Polym 74:59–67
- Bernkop-Schnurch A, Kast CE, Richter MF. (2001). Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J Control Release 71:277–85
- Calija B, Cekic N, Savic S, et al. (2013). pH-sensitive microparticles for oral drug delivery based on alginate/oligochitosan/Eudragit(®) L100-55 “sandwich” polyelectrolyte complex. Colloids Surf B Biointerfaces 110:395–402
- Everett TR, Wilkinson IB, Mahendru AA, et al. (2014). S-Nitrosoglutathione improves haemodynamics in early-onset pre-eclampsia. Br J Clin Pharmacol 78:660–9
- Freeman HJ. (2009). Long-term natural history of Crohn’s disease. World J Gastroenterol 15:1315–18
- Friedman A, Friedman J. (2009). New biomaterials for the sustained release of nitric oxide: past, present and future. Expert Opin Drug Deliv 6:1113–22
- Furuhashi S, Sugita H, Takamori H, et al. (2012). NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells. Int J Oncol 40:807–15
- Georgii JL, Amadeu TP, Seabra AB, et al. (2011). Topical S-nitrosoglutathione-releasing hydrogel improves healing of rat ischaemic wounds. J Tissue Eng Regen Med 5:612–19
- Heines SV. (1958). Peter Griess – discoverer of diazo compounds. J Chem Educ 35:187
- Hornyak I, Marosi K, Kiss L, et al. (2012). Increased stability of S-nitrosothiol solutions via pH modulations. Free Radic Res 46:214–25
- Ignarro LJ, Lippton H, Edwards JC, et al. (1981). Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218:739–49
- Jerca L, Jerca O, Constantinescu I. (2002). Mechanism of action and biochemical effects of nitric oxide (NO). J Prev Med 10:35–45
- Josephy PD, Rehorek D, Janzen EG. (1984). Electron spin resonance spin trapping of thiyl, radicals from the decomposition of thionitrites. Tetrahedron Lett 25:1685–8
- Katsumi H, Nishikawa M, Ma SF, et al. (2004). Physicochemical, tissue distribution, and vasodilation characteristics of nitrosated serum albumin: delivery of nitric oxide in vivo. J Pharm Sci 93:2343–52
- Katsumi H, Nishikawa M, Yamashita F, et al. (2005). Development of polyethylene glycol-conjugated poly-S-nitrosated serum albumin, a novel S-nitrosothiol for prolonged delivery of nitric oxide in the blood circulation in vivo. J Pharmacol Exp Ther 314:1117–24
- Khan M, Im YB, Shunmugavel A, et al. (2009). Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. J Neuroinflamm 6:32. doi:10.1186/1742-2094-6-32
- Khan M, Sakakima H, Dhammu TS, et al. (2011). S-nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats. J Neuroinflamm 8:78. doi: 10.1186/1742-2094-8-78
- Kilbourn RG. (1996). Nitric oxide: moving towards the clinic. Mol Med Today 2:324
- Lundberg JO, Weitzberg E, Gladwin MT. (2008). The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7:156–67
- Mann HB, Whitney DR. (1947). On a test of whether one of two random variables is stochastically larger than the other. Ann Math Statist 18:50–60
- Marcato PD, Adami LF, de Melo Barbosa R, et al. (2013). Development of a sustained-release system for nitric oxide delivery using alginate/chitosan nanoparticles. Curr Nanosci 9:1–7
- Moncada S, Palmer RM, Higgs EA. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–42
- Parent M, Dahboul F, Schneider R, et al. (2013). A complete physicochemical identity card of S-nitrosoglutathione. Curr Pharm Anal 9:31–42
- Ronzani C, Safar R, Diab R, et al. (2014). Viability and gene expression responses to polymeric nanoparticles in human and rat cells. Cell Biol Toxicol 30:137–46
- Safar R, Ronzani C, Diab R, et al. (2015). Human monocyte response to S-nitrosoglutathione-loaded nanoparticles: uptake, viability, and transcriptome. Mol Pharm 12:554–61
- Saraiva J, Marotta-Oliveira SS, Cicillini SA, et al. (2011). Nanocarriers for nitric oxide delivery. J Drug Deliv 2011:936438
- Savidge TC, Newman P, Pothoulakis C, et al. (2007). Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione. Gastroenterology 132:1344–58
- Saville B. (1958). A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 83:670–2
- Schulz K, Kerber S, Kelm M. (1999). Reevaluation of the Griess method for determining NO/NO2− in aqueous and protein-containing samples. Nitric Oxide 3:225–34
- Seabra AB, da Silva R, de Oliveira MG. (2005). Polynitrosated polyesters: preparation, characterization, and potential use for topical nitric oxide release. Biomacromolecules 6:2512
- Servetnyk Z, Jiang S, Hjelte L, et al. (2011). The effect of S-nitrosoglutathione and L-cysteine on chloride efflux from cystic fibrosis airway epithelial cells. Exp Mol Pathol 90:79–83
- Shah SU, Martinho N, Socha M, et al. (2015). Synthesis and characterization of S-nitrosoglutathione-oligosaccharide-chitosan as a nitric oxide donor. Exp Opin Drug Deliv 12:1209–23
- Shin HY, George SC. (2001). Microscopic modeling of NO and S-nitrosoglutathione kinetics and transport in human airways. J Appl Physiol 90:777–88
- Singh RJ, Hogg N, Joseph J, et al. (1996a). Mechanism of nitric oxide release from S-nitrosothiols. J Biol Chem 271:18596–603
- Singh SP, Wishnok JS, Keshive M, et al. (1996b). The chemistry of the S-nitrosoglutathione/glutathione system. Proc Natl Acad Sci USA 93:14428–33
- Sosnik A. (2014). Alginate particles as platform for drug delivery by the oral route: state-of-the-art. ISRN Pharm 2014:17
- Thomsen OO, Cortot A, Jewell D, et al. (1998). A comparison of budesonide and mesalamine for active Crohn’s disease. International Budesonide-Mesalamine Study Group. N Engl J Med 339:370–4
- Tonnesen HH, Karlsen J. (2002). Alginate in drug delivery systems. Drug Dev Ind Pharm 28:621–30
- Wolfe DL, Forland SC, Benet LZ. (1973). Drug transfer across intact rat intestinal mucosa following surgical removal of serosa and muscularis externa. J Pharm Sci 62:200–5
- Yousefpour P, Atyabi F, Dinarvand R, et al. (2011). Preparation and comparison of chitosan nanoparticles with different degrees of glutathione thiolation. Daru 19:367–75